Active	Status	Sponsor type	Region	Phase	Filter
12 Active 2 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chu, Ralph Y
NCT04747834: Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery	Completed	N/A	100	US	MICOR-304	Carl Zeiss Meditec, Inc., Carl Zeiss Meditec Cataract Technology, Inc.	Cataract	01/22	01/22
NCT06264232: AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal	Recruiting	N/A	286	US	Cataract Surgery	Carl Zeiss Meditec, Inc., ORA, Inc.	Cataract Senile	12/25	05/26
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
Greenwood, Michael
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)	Recruiting	3	528	US	MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet	Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex	Cataract	12/24	01/25
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
Callaghan, Angela
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)	Recruiting	3	528	US	MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet	Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex	Cataract	12/24	01/25
Thiede, Sarah
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)	Recruiting	3	528	US	MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet	Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex	Cataract	12/24	01/25
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chu, Ralph Y
NCT04747834: Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery	Completed	N/A	100	US	MICOR-304	Carl Zeiss Meditec, Inc., Carl Zeiss Meditec Cataract Technology, Inc.	Cataract	01/22	01/22
NCT06264232: AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal	Recruiting	N/A	286	US	Cataract Surgery	Carl Zeiss Meditec, Inc., ORA, Inc.	Cataract Senile	12/25	05/26
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
Greenwood, Michael
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)	Recruiting	3	528	US	MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet	Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex	Cataract	12/24	01/25
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
Callaghan, Angela
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)	Recruiting	3	528	US	MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet	Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex	Cataract	12/24	01/25
Thiede, Sarah
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)	Recruiting	3	528	US	MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet	Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex	Cataract	12/24	01/25
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26